Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
IDEXX reports before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-08-04 | +$20.25 (+3.57%) | $39.89 (7.03%) | -$3.31 (-0.56%) | $25.65 (4.36%) |
| 2026-05-05 | -$0.15 (-0.03%) | $34.72 (6.17%) | +$16.26 (+2.89%) | $30.20 (5.36%) |
| 2026-02-02 | -$30.86 (-4.60%) | $36.38 (5.43%) | -$7.04 (-1.10%) | $21.45 (3.35%) |
| 2025-11-03 | +$93.43 (+14.84%) | $43.27 (6.87%) | -$0.82 (-0.11%) | $19.91 (2.75%) |
| 2025-08-04 | +$147.24 (+27.49%) | $44.39 (8.29%) | -$40.84 (-5.98%) | $42.40 (6.21%) |
| 2025-05-01 | +$38.73 (+8.95%) | $19.88 (4.59%) | +$0.52 (+0.11%) | $17.34 (3.68%) |
| 2025-02-03 | +$46.99 (+11.13%) | $29.67 (7.03%) | -$4.01 (-0.85%) | $7.47 (1.59%) |
| 2024-10-31 | -$44.16 (-9.79%) | $25.26 (5.60%) | +$10.36 (+2.55%) | $13.51 (3.32%) |
| Avg Abs Move | 10.05% | 6.38% | 1.77% | 3.83% |
Historical price behavior shows highly volatile reactions to IDEXX earnings, with an average absolute Day 0 move of 10.05% — well above typical market responses. The most dramatic reaction came in Q3 2025, when the stock surged 27.49% on the day of the report, followed by a -5.98% pullback the next session. More recently, Q2 2026 produced a 3.57% Day 0 gain with minimal follow-through.
The pattern reveals asymmetric risk: positive surprises have driven explosive upside (Q3 2025's +27.49%, Q4 2025's +14.84%, Q1 2026's +11.13%), while disappointments trigger sharp selloffs (Q4 2024's -9.79%, Q1 2026's -4.60%). Day +1 moves average 1.77% in absolute terms, suggesting initial reactions tend to stick rather than reverse. Intraday volatility is also elevated, with Day 0 trading ranges averaging 6.38% — investors should expect significant price swings regardless of the earnings outcome.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 21) |
| Expected Move | $47.68 (8.65%) |
| Expected Range | $503.53 to $598.89 |
| Implied Volatility | 52.68% |
The options market is pricing an 8.65% expected move for the November expiration, slightly below the 10.05% average historical Day 0 move but well within the range of recent outcomes. This suggests options traders are anticipating meaningful volatility but not the extreme moves seen in Q3 2025 or Q1 2026.
Part 3: What Analysts Are Saying
Analysts maintain a Moderate Buy consensus on IDEXX with an average rating of 4.27 out of 5.0, reflecting broad confidence in the company's long-term growth trajectory. The current breakdown shows 9 Strong Buy ratings, 1 Moderate Buy, and 5 Hold ratings, with no sell recommendations. This represents an improved sentiment trend, as the Strong Buy count increased from 8 to 9 over the past month while the overall rating ticked up from 4.21 to 4.27.
The average price target of $713.23 implies 29.4% upside from the current price of $551.21, suggesting analysts see significant value despite near-term execution risks. Price targets span a wide range from a low of $557.00 to a high of $823.00, reflecting differing views on the pace of recovery in veterinary visit trends and the company's ability to drive margin expansion.
Recent target adjustments illustrate this divergence. Goldman Sachs' October 16 initiation at $740 (Buy rating) represents the bullish case, emphasizing IDEXX's market leadership and recurring revenue model. Conversely, UBS cut its target from $670 to $627 on October 27 while maintaining a Hold rating, citing concerns about wellness visit headwinds. Barclays' reduction from $800 to $710 (Overweight maintained) reflects valuation recalibration rather than fundamental concern. The consensus suggests analysts believe IDEXX's competitive moat and growth drivers remain intact, but near-term multiple expansion depends on demonstrating sustained improvement in core volume metrics.
Part 4: Technical Picture
IDEXX enters earnings with a deteriorating technical setup that has shifted dramatically in recent weeks. The Barchart Technical Opinion currently shows a 24% Sell signal, a significant weakening from 8% Sell one week ago and 100% Sell one month ago. This progression indicates mounting selling pressure as the stock approaches its earnings report.
Timeframe Analysis:
- Short-term (Hold): Neutral signal suggests near-term momentum has stalled after recent weakness
- Medium-term (50% Sell): Moderate sell signal reflects deteriorating intermediate-term trend structure
- Long-term (50% Sell): Moderate sell signal indicates longer-term uptrend has lost momentum
Trend Characteristics: The trend is characterized as Weak with Weakest directional momentum, indicating IDEXX is in a vulnerable technical position heading into the earnings catalyst with limited support from momentum indicators.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $564.31 | 50-Day MA | $534.27 |
| 10-Day MA | $561.59 | 100-Day MA | $547.13 |
| 20-Day MA | $543.85 | 200-Day MA | $572.62 |
At $551.21, IDEXX trades below its 200-day moving average of $572.62, a bearish configuration that suggests the longer-term uptrend has broken down. The stock is also below its 5-day ($564.31) and 10-day ($561.59) moving averages, confirming near-term weakness. However, it remains above its 20-day ($543.85), 50-day ($534.27), and 100-day ($547.13) averages, providing potential support zones if selling accelerates. The 200-day average at $572.62 now represents key overhead resistance — a post-earnings rally would need to reclaim this level to restore the longer-term bullish structure. The overall technical setup is cautionary heading into earnings, with weak momentum and a breakdown below the 200-day average suggesting limited technical support for the stock if results or guidance disappoint.